Victory Capital Management Inc Coh Bar, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$0.17 - $0.34 $7 - $14	42 Added 0.39%	10,754 $2,000
Q1 2022 May 04, 2022	BUY	$0.25 - $0.43 $111 - $191	446 Added 4.34%	10,712 $3,000
Q4 2021 Feb 07, 2022	BUY	$0.34 - $1.0 $3,490 - $10,266	10,266 New	10,266 $4,000
Q2 2020 Aug 07, 2020	SELL	$1.08 - $4.0 $6,015 - $22,280	-5,570 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.01 - $2.74 $128 - $347	-127 Reduced 2.23%	5,570 $6,000
Q4 2019 Feb 04, 2020	SELL	$1.2 - $2.34 $96 - $187	-80 Reduced 1.38%	5,697 $13,000
Q3 2019 Nov 12, 2019	BUY	$1.3 - $1.76 $7,510 - $10,167	5,777 New	5,777 $8,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.